Active Filters

  • (-) PSI Authors = Schibli, Roger
Search Results 1 - 20 of 101

Pages

  • CSV Spreadsheet
  • Excel Spreadsheet
  • RSS Feed
Select Page
Development of a new class of PSMA radioligands comprising ibuprofen as an albumin-binding entity
Deberle, L. M., Benešová, M., Umbricht, C. A., Borgna, F., Büchler, M., Zhernosekov, K., … Müller, C. (2020). Development of a new class of PSMA radioligands comprising ibuprofen as an albumin-binding entity. Theranostics, 10(4), 1678-1693. https://doi.org/10.7150/thno.40482
The A/T/N model applied through imaging biomarkers in a memory clinic
Dodich, A., Mendes, A., Assal, F., Chicherio, C., Rakotomiaramanana, B., Andryszak, P., … Garibotto, V. (2020). The A/T/N model applied through imaging biomarkers in a memory clinic. European Journal of Nuclear Medicine and Molecular Imaging, 47(2), 247-255. https://doi.org/10.1007/s00259-019-04536-9
<sup>165</sup>Er: a new candidate for Auger electron therapy and its possible cyclotron production from natural holmium targets
Gracheva, N., Carzaniga, T. S., Schibli, R., Braccini, S., & van der Meulen, N. P. (2020). 165Er: a new candidate for Auger electron therapy and its possible cyclotron production from natural holmium targets. Applied Radiation and Isotopes, 159, 109079 (8 pp.). https://doi.org/10.1016/j.apradiso.2020.109079
L1 cell adhesion molecule confers radioresistance to ovarian cancer and defines a new cancer stem cell population
Terraneo, N., Jacob, F., Peitzsch, C., Dubrovska, A., Krudewig, C., Huang, Y. L., … Grünberg, J. (2020). L1 cell adhesion molecule confers radioresistance to ovarian cancer and defines a new cancer stem cell population. Cancers, 12(1), 217 (17 pp.). https://doi.org/10.3390/cancers12010217
Diastereomerically pure 6<em>R</em>- and 6<em>S</em>-3'-aza-2'-<sup>18</sup>F-fluoro-5-methyltetrahydrofolates show unprecedentedly high uptake in folate receptor-positive KB tumors
Boss, S. D., Müller, C., Siwowska, K., Schmid, R. M., Groehn, V., Schibli, R., & Ametamey, S. M. (2019). Diastereomerically pure 6R- and 6S-3'-aza-2'-18F-fluoro-5-methyltetrahydrofolates show unprecedentedly high uptake in folate receptor-positive KB tumors. Journal of Nuclear Medicine, 60(1), 135-141. https://doi.org/10.2967/jnumed.118.213314
Production and characterization of no-carrier-added <sup>161</sup>Tb as an alternative to the clinically-applied <sup>177</sup>Lu for radionuclide therapy
Gracheva, N., Müller, C., Talip, Z., Heinitz, S., Köster, U., Zeevaart, J. R., … van der Meulen, N. P. (2019). Production and characterization of no-carrier-added 161Tb as an alternative to the clinically-applied 177Lu for radionuclide therapy. EJNMMI Radiopharmacy and Chemistry, 4, 12 (16 pp.). https://doi.org/10.1186/s41181-019-0063-6
Recent progress in allosteric modulators for GluN2A subunit and development of GluN2A-selective nuclear imaging probes
He, Y., Mu, L., Ametamey, S. M., & Schibli, R. (2019). Recent progress in allosteric modulators for GluN2A subunit and development of GluN2A-selective nuclear imaging probes. Journal of Labelled Compounds and Radiopharmaceuticals, 62(8), 552-560. https://doi.org/10.1002/jlcr.3744
High‐resolution SPECT imaging of stimuli‐responsive soft microrobots
Iacovacci, V., Blanc, A., Huang, H., Ricotti, L., Schibli, R., Menciassi, A., … Nelson, B. J. (2019). High‐resolution SPECT imaging of stimuli‐responsive soft microrobots. Small, 15(34), 1900709 (7 pp.). https://doi.org/10.1002/smll.201900709
Comparison of desferrioxamine and NODAGA for the gallium-68 labeling of exendin-4
Kaeppeli, S. A. M., Schibli, R., Mindt, T. L., & Behe, M. (2019). Comparison of desferrioxamine and NODAGA for the gallium-68 labeling of exendin-4. EJNMMI Radiopharmacy and Chemistry, 4(1), 9 (11 pp.). https://doi.org/10.1186/s41181-019-0060-9
Exendin-4 derivatives with an albumin-binding moiety show decreased renal retention and improved GLP-1 receptor targeting
Kaeppeli, S. A. M., Jodal, A., Gotthardt, M., Schibli, R., & Behe, M. (2019). Exendin-4 derivatives with an albumin-binding moiety show decreased renal retention and improved GLP-1 receptor targeting. Molecular Pharmaceutics, 16(9), 3760-3769. https://doi.org/10.1021/acs.molpharmaceut.9b00271
Combination of proton therapy and radionuclide therapy in mice: preclinical pilot sudy at the Paul Scherrer Institute
Müller, C., De Prado Leal, M., Dominietto, M. D., Umbricht, C. A., Safai, S., Perrin, R. L., … Lomax, A. J. (2019). Combination of proton therapy and radionuclide therapy in mice: preclinical pilot sudy at the Paul Scherrer Institute. Pharmaceutics, 11(9), 450 (13 pp.). https://doi.org/10.3390/pharmaceutics11090450
Preclinical investigations and first-in-human application of <sup>152</sup>Tb-PSMA-617 for PET/CT imaging of prostate cancer
Müller, C., Singh, A., Umbricht, C. A., Kulkarni, H. R., Johnston, K., Benešová, M., … Baum, R. P. (2019). Preclinical investigations and first-in-human application of 152Tb-PSMA-617 for PET/CT imaging of prostate cancer. EJNMMI Research, 9(1), 68 (10 pp.). https://doi.org/10.1186/s13550-019-0538-1
Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancer
Müller, C., Umbricht, C. A., Gracheva, N., Tschan, V. J., Pellegrini, G., Bernhardt, P., … van der Meulen, N. P. (2019). Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging, 46(9), 1919-1930. https://doi.org/10.1007/s00259-019-04345-0
Targeted <sup>64</sup>Cu-labeled gold nanoparticles for dual imaging with positron emission tomography and optical imaging
Pretze, M., van der Meulen, N.  P., Wängler, C., Schibli, R., & Wängler, B. (2019). Targeted 64Cu-labeled gold nanoparticles for dual imaging with positron emission tomography and optical imaging. Journal of Labelled Compounds and Radiopharmaceuticals, 62(8), 471-482. https://doi.org/10.1002/jlcr.3736
Elucidating the structure−activity relationship of the pentaglutamic acid sequence of minigastrin with cholecystokinin receptor subtype 2
Ritler, A., Shoshan, M. S., Deupi, X., Wilhelm, P., Schibli, R., Wennemers, H., & Béhé, M. (2019). Elucidating the structure−activity relationship of the pentaglutamic acid sequence of minigastrin with cholecystokinin receptor subtype 2. Bioconjugate Chemistry, 30(3), 657-666. https://doi.org/10.1021/acs.bioconjchem.8b00849
First clinico-pathological evidence of a non PSMA-related uptake mechanism for <sup>68</sup>Ga-PSMA-11 in salivary glands
Rupp, N. J., Umbricht, C. A., Pizzuto, D. A., Lenggenhager, D., Töpfer, A., Müller, J., … Burger, I. A. (2019). First clinico-pathological evidence of a non PSMA-related uptake mechanism for 68Ga-PSMA-11 in salivary glands. Journal of Nuclear Medicine, 60(9), 1270-1276. https://doi.org/10.2967/jnumed.118.222307
<sup>18</sup>F-AzaFol for detection of folate receptor-β positive macrophages in experimental interstitial lung disease - a proof-of-concept study
Schniering, J., Benešová, M., Brunner, M., Haller, S., Cohrs, S., Frauenfelder, T., … Maurer, B. (2019). 18F-AzaFol for detection of folate receptor-β positive macrophages in experimental interstitial lung disease - a proof-of-concept study. Frontiers in Immunology, 10, 2724 (15 pp.). https://doi.org/10.3389/fimmu.2019.02724
Therapeutic potential of <sup>47</sup>Sc in comparison to <sup>177</sup>Lu and <sup>90</sup>Y: preclinical investigations
Siwowska, K., Guzik, P., Domnanich, K. A., Monné Rodríguez, J. M., Bernhardt, P., Ponsard, B., … Müller, C. (2019). Therapeutic potential of 47Sc in comparison to 177Lu and 90Y: preclinical investigations. Pharmaceutics, 11(8), 424 (13 pp.). https://doi.org/10.3390/pharmaceutics11080424
Alpha-PET for prostate cancer: preclinical investigation using <sup>149</sup>Tb-PSMA-617
Umbricht, C. A., Köster, U., Bernhardt, P., Gracheva, N., Johnston, K., Schibli, R., … Müller, C. (2019). Alpha-PET for prostate cancer: preclinical investigation using 149Tb-PSMA-617. Scientific Reports, 9, 17800 (10 pp.). https://doi.org/10.1038/s41598-019-54150-w
Implementation of a new separation method to produce qualitatively improved <sup>64</sup>Cu
van der Meulen, N. P., Hasler, R., Blanc, A., Farkas, R., Benešová, M., Talip, Z., … Schibli, R. (2019). Implementation of a new separation method to produce qualitatively improved 64Cu. Journal of Labelled Compounds and Radiopharmaceuticals, 62(8), 460-470. https://doi.org/10.1002/jlcr.3730
 

Pages